Orthofix director granted 14,965 stock units
Orthofix Medical Inc. director Michael E. Paolucci received an equity compensation grant of 14,965 deferred stock units of common stock at no cost.
Rhea-AI Filing Summary
Orthofix Medical Inc. director Michael E. Paolucci received an equity compensation grant of 14,965 deferred stock units of common stock at no cost. These units vest in full on the first anniversary of the grant date, subject to his continued service. Each vested unit will convert into one share of common stock within 45 days after his service with the company ends. Following this award, he directly holds 102,727 units and shares, including 73,541 previously reported deferred stock units and 814 shares acquired under Orthofix's Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 14,965 shares
Grant/Award
1 txn
Insider
Paolucci Michael E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 14,965 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 102,727 shares (Direct)
Footnotes (2)
- F1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
- F2. Includes 73,541 previously reported deferred stock units and 814 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
Key Figures
Deferred stock units granted: 14,965 units
Grant price per unit: $0.00 per unit
Total holdings after grant: 102,727 units and shares
+4 more
7 metrics
Deferred stock units granted
14,965 units
Equity award on 2026-06-10
Grant price per unit
$0.00 per unit
Equity compensation grant
Total holdings after grant
102,727 units and shares
Direct ownership following transaction
Previously reported deferred stock units
73,541 units
Existing DSUs before new grant
Shares via Stock Purchase Plan
814 shares
Acquired under Orthofix's SPP on 2025-10-31
Vesting period
1 year
Deferred stock units vest on first anniversary of grant
Settlement window after termination
45 days
Vested units convert to stock within 45 days
Key Terms
deferred stock units, Stock Purchase Plan, Rule 16b-3(b)(5), Section 16(b)
4 terms
deferred stock units financial
"Represents an award of deferred stock units that vest in full on the first anniversary of the grant date"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Stock Purchase Plan financial
"Includes 73,541 previously reported deferred stock units and 814 shares acquired under Orthofix's Stock Purchase Plan"
A stock purchase plan is a company-run program that lets employees or qualifying investors buy the company’s shares regularly, often through paycheck deductions and sometimes at a discounted price or with matching contributions. It matters because it encourages ownership—like a workplace discount for buying company products—aligning interests between holders and managers, while affecting share supply and potential value for outside investors.
Rule 16b-3(b)(5) regulatory
"Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5)"
Section 16(b) regulatory
"share acquisitions under the plan are exempt from Section 16(b)"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
FAQ
What insider transaction did Orthofix (OFIX) report for Michael E. Paolucci?
Orthofix reported that director Michael E. Paolucci received 14,965 deferred stock units as an equity award. The units were granted at no cost and represent a contingent right to receive common shares, expanding his overall equity-based interest in the company.
How do Michael E. Paolucci’s new Orthofix deferred stock units vest?
The 14,965 deferred stock units granted to Michael E. Paolucci vest in full on the first anniversary of the grant date. Vesting is conditioned on his continued service with Orthofix through that date, aligning the award with ongoing board participation.
When will Michael E. Paolucci receive Orthofix common stock for these units?
Once vested, the deferred stock units will settle into Orthofix common stock within 45 days after Paolucci’s termination of service. Each deferred stock unit converts into one share, deferring actual share delivery until he leaves the company.
What is Michael E. Paolucci’s total Orthofix equity position after this grant?
After the grant, Michael E. Paolucci directly holds 102,727 units and shares in Orthofix. This total includes the new 14,965 deferred stock units, 73,541 previously reported deferred stock units, and 814 shares acquired under Orthofix's Stock Purchase Plan.
What is Orthofix’s Stock Purchase Plan mentioned in Michael E. Paolucci’s filing?
Orthofix's Stock Purchase Plan is described as a "Stock Purchase Plan" under Rule 16b-3(b)(5). Shares acquired under this plan, such as Paolucci’s 814 shares, are exempt from Section 16(b) short-swing profit rules, simplifying insider participation in the program.
AI-generated analysis. How Rhea-AI works. Not financial advice.
